eXoZymes, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +14.5% | +32.5% | +266.3% | -54.2% | |
| – | +40.4% | -17.4% | +791.6% | -63.6% | |
| – | +2.0% | -88.1% | +14,508.3% | -68.7% | |
| – | +2.0% | -88.1% | +14,508.3% | -68.7% | |
| – | +72.8% | +9.0% | -16.4% | -29.8% | |
| – | +14.3% | +200.3% | -33.7% | -1.5% | |
| – | +58.3% | +280.7% | -44.8% | +17.5% | |
| – | +8.6% | +55.2% | +2.2% | +41.8% | |
| – | +44.3% | +82.2% | +31.5% | +33.7% | |
| – | +14.7% | -128.0% | – | -67.4% | |
| – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +3.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.